Suchergebnisse - "Bapat, Sagar P"

PubPharm (27)

1

Test performance evaluation of SARS-CoV-2 serological assays

enthalten in: bioRxiv.org | 2024

von Whitman, J. | Hiatt, J. | Mowery, C. | +69

2

Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity

enthalten in: bioRxiv.org | 2024

von Lynch, K. | Whitman, J. | Lacanienta, N. | +11

3

Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia report

enthalten in: Annals of the New York Academy of Sciences | 2023

von Cable, J. | Rathmell, J. | Pearce, E. | +26

4

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DIABETES AND RELATED DISORDERS

enthalten in: Europäisches Patentamt | 2023

von BAPAT SAGAR P | ZHENG YE | EVANS RONALD | +3

5

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

enthalten in: Nature | 2022

von Carnevale, J. | Shifrut, E. | Kale, N. | +30

CommentIn: Am J Transplant. 2022 Dec;22(12):2715. - PMID 36458703

6

Compositions and methods for treating age-related diabetes and related disorders

enthalten in: Europäisches Patentamt | 2022

von BAPAT SAGAR P | ZHENG YE | EVANS RONALD | +3

7

Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism

enthalten in: Gastroenterology | 2022

von Choi, J. | Oh, T. | Jung, H. | +34

ErratumIn: Gastroenterology. 2023 Feb;164(2):313. - PMID 36464508

8

Obesity alters pathology and treatment response in inflammatory disease

enthalten in: Nature | 2022

von Bapat, S. | Whitty, C. | Mowery, C. | +40

CommentIn: Nat Rev Immunol. 2022 May;22(5):274-275. - PMID 35393549

9

Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL

enthalten in: Cancer discovery | 2021

von Nix, M. | Mandal, K. | Geng, H. | +18

10

A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood

enthalten in: Science advances | 2021

von Ng, D. | Granados, A. | Santos, Y. | +29